Mercer Global Advisors Inc. ADV Boosts Stock Position in Integer Holdings Co. (NYSE:ITGR)

Mercer Global Advisors Inc. ADV boosted its holdings in shares of Integer Holdings Co. (NYSE:ITGR) by 9.0% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 30,771 shares of the medical equipment provider’s stock after purchasing an additional 2,546 shares during the period. Mercer Global Advisors Inc. ADV’s holdings in Integer were worth $3,563,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of ITGR. GSA Capital Partners LLP purchased a new position in shares of Integer during the first quarter valued at approximately $786,000. Public Employees Retirement Association of Colorado boosted its holdings in Integer by 3,260.1% in the fourth quarter. Public Employees Retirement Association of Colorado now owns 285,439 shares of the medical equipment provider’s stock valued at $28,281,000 after acquiring an additional 276,944 shares in the last quarter. Norges Bank purchased a new position in Integer during the 4th quarter valued at $18,697,000. Blue Trust Inc. raised its holdings in Integer by 460.4% in the 2nd quarter. Blue Trust Inc. now owns 5,643 shares of the medical equipment provider’s stock worth $658,000 after purchasing an additional 4,636 shares in the last quarter. Finally, UniSuper Management Pty Ltd purchased a new stake in shares of Integer in the 1st quarter worth about $976,000. Institutional investors own 99.29% of the company’s stock.

Insider Buying and Selling at Integer

In other news, Director Jean M. Hobby sold 11,960 shares of the company’s stock in a transaction that occurred on Wednesday, July 31st. The shares were sold at an average price of $119.66, for a total value of $1,431,133.60. Following the transaction, the director now owns 2,280 shares in the company, valued at $272,824.80. The sale was disclosed in a legal filing with the SEC, which is available at this link. 2.00% of the stock is owned by company insiders.

Integer Price Performance

ITGR stock opened at $129.33 on Monday. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.96 and a current ratio of 3.29. The firm has a 50 day moving average price of $122.98 and a 200-day moving average price of $118.66. Integer Holdings Co. has a 52-week low of $69.40 and a 52-week high of $131.87. The firm has a market capitalization of $4.33 billion, a price-to-earnings ratio of 44.75, a PEG ratio of 1.81 and a beta of 1.09.

Integer (NYSE:ITGR) last released its earnings results on Thursday, July 25th. The medical equipment provider reported $1.30 EPS for the quarter, topping the consensus estimate of $1.24 by $0.06. Integer had a return on equity of 11.48% and a net margin of 6.31%. The business had revenue of $436.20 million for the quarter, compared to the consensus estimate of $437.00 million. During the same period in the previous year, the company posted $1.14 earnings per share. The company’s revenue for the quarter was up 9.0% compared to the same quarter last year. Equities research analysts forecast that Integer Holdings Co. will post 5.31 EPS for the current fiscal year.

Analyst Ratings Changes

Several equities analysts recently issued reports on ITGR shares. Benchmark reiterated a “buy” rating and set a $130.00 price target on shares of Integer in a research report on Friday, August 2nd. Oppenheimer initiated coverage on Integer in a report on Tuesday, July 16th. They set an “outperform” rating and a $135.00 target price on the stock. Two analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $133.86.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.